• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number TGM262610
Medical Device Problem Code Malposition of Device (2616)
Health Effect - Clinical Code Obstruction/Occlusion (2422)
Date of Event 05/28/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).It should be noted that the gore® tag® conformable thoracic stent graft with active control system instructions for use state, "complications associated with the use may include but are not limited to: improper stent graft placement and branch vessel occlusion or obstruction".W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event or Problem Description
On (b)(6) 2022, this patient underwent emergency endovascular treatment of a traumatic thoracic aortic transection resulting from a motor vehicle accident.A conformable gore® tag® thoracic endoprosthesis with active control was inserted and advanced to just below the carotid artery.The proximal uncovered stent apices were placed at the ostium of the left common carotid artery, and the stent graft was deployed.However, the fabric sleeve of the device fully covered the 9mm ostium of the carotid artery after deployment, and impeded flow into the left common carotid artery.To treat, the physician advanced a mob catheter and inflated it at the proximal and middle portions of the stent graft and was able to pull the stent graft distal to uncover the left common carotid artery and restore blood flow.The patient tolerated the procedure.The fsa noted that the sleeve at the proximal end of the stent graft seemed longer than 4mm.The review of the manufacturing records for the device verified the lot met all pre-release specifications.A response regarding this event was not requested by the physician.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WOODY SPRINGS B/P
3450 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
jaskaran parhar
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key15164315
Report Number2017233-2022-03185
Device Sequence Number2200220
Product Code MIH
UDI-Device Identifier00733132646920
UDI-Public00733132646920
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P040043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 08/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/29/2024
Device Model NumberTGM262610
Device Catalogue NumberTGM262610
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/28/2022
Initial Report FDA Received Date08/04/2022
Date Device Manufactured12/01/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device A
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient SexMale
-
-